S&P 500   4,345.82 (+0.37%)
DOW   34,091.79 (+0.06%)
QQQ   361.11 (+0.91%)
AAPL   176.18 (+1.29%)
MSFT   320.00 (+0.15%)
META   302.08 (+2.15%)
GOOGL   131.63 (+0.91%)
AMZN   131.11 (+1.38%)
TSLA   255.58 (-0.05%)
NVDA   419.27 (+2.22%)
NIO   8.59 (+1.66%)
BABA   88.24 (+4.91%)
AMD   97.51 (+1.46%)
T   15.09 (-1.44%)
F   12.53 (+2.70%)
MU   69.41 (+2.22%)
CGC   0.86 (+11.44%)
GE   112.71 (-0.25%)
DIS   81.99 (-0.89%)
AMC   7.92 (+2.86%)
PFE   32.73 (-0.37%)
PYPL   58.68 (+0.10%)
NFLX   382.80 (-0.35%)
S&P 500   4,345.82 (+0.37%)
DOW   34,091.79 (+0.06%)
QQQ   361.11 (+0.91%)
AAPL   176.18 (+1.29%)
MSFT   320.00 (+0.15%)
META   302.08 (+2.15%)
GOOGL   131.63 (+0.91%)
AMZN   131.11 (+1.38%)
TSLA   255.58 (-0.05%)
NVDA   419.27 (+2.22%)
NIO   8.59 (+1.66%)
BABA   88.24 (+4.91%)
AMD   97.51 (+1.46%)
T   15.09 (-1.44%)
F   12.53 (+2.70%)
MU   69.41 (+2.22%)
CGC   0.86 (+11.44%)
GE   112.71 (-0.25%)
DIS   81.99 (-0.89%)
AMC   7.92 (+2.86%)
PFE   32.73 (-0.37%)
PYPL   58.68 (+0.10%)
NFLX   382.80 (-0.35%)
S&P 500   4,345.82 (+0.37%)
DOW   34,091.79 (+0.06%)
QQQ   361.11 (+0.91%)
AAPL   176.18 (+1.29%)
MSFT   320.00 (+0.15%)
META   302.08 (+2.15%)
GOOGL   131.63 (+0.91%)
AMZN   131.11 (+1.38%)
TSLA   255.58 (-0.05%)
NVDA   419.27 (+2.22%)
NIO   8.59 (+1.66%)
BABA   88.24 (+4.91%)
AMD   97.51 (+1.46%)
T   15.09 (-1.44%)
F   12.53 (+2.70%)
MU   69.41 (+2.22%)
CGC   0.86 (+11.44%)
GE   112.71 (-0.25%)
DIS   81.99 (-0.89%)
AMC   7.92 (+2.86%)
PFE   32.73 (-0.37%)
PYPL   58.68 (+0.10%)
NFLX   382.80 (-0.35%)
S&P 500   4,345.82 (+0.37%)
DOW   34,091.79 (+0.06%)
QQQ   361.11 (+0.91%)
AAPL   176.18 (+1.29%)
MSFT   320.00 (+0.15%)
META   302.08 (+2.15%)
GOOGL   131.63 (+0.91%)
AMZN   131.11 (+1.38%)
TSLA   255.58 (-0.05%)
NVDA   419.27 (+2.22%)
NIO   8.59 (+1.66%)
BABA   88.24 (+4.91%)
AMD   97.51 (+1.46%)
T   15.09 (-1.44%)
F   12.53 (+2.70%)
MU   69.41 (+2.22%)
CGC   0.86 (+11.44%)
GE   112.71 (-0.25%)
DIS   81.99 (-0.89%)
AMC   7.92 (+2.86%)
PFE   32.73 (-0.37%)
PYPL   58.68 (+0.10%)
NFLX   382.80 (-0.35%)
OTCMKTS:BPSR

Organicell Regenerative Medicine (BPSR) Stock Forecast, Price & News

$0.01
0.00 (0.00%)
(As of 09/21/2023 ET)
Compare
Today's Range
$0.0111
▼
$0.0120
50-Day Range
$0.01
▼
$0.02
52-Week Range
$0.04
▼
$0.63
Volume
389,266 shs
Average Volume
3.31 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsFinancialsHeadlinesSEC FilingsShort Interest

BPSR stock logo

About Organicell Regenerative Medicine (OTCMKTS:BPSR) Stock

Biotech Products Services & Research, Inc. is a clinical-stage biopharmaceutical company. It focuses on the development of biological therapeutics for the treatment of degenerative diseases and to provide other related services. The firm also focuses on processing, distribution and supply of biologically processed cellular and tissue-based products developed from internally based research and development activities and also provides healthcare, anti-aging, and regenerative services. The company was founded by John Goodhew, Albert Mitrani and Maria Ines Mitrani on August 9, 2011 and is headquartered in Miami, FL.

BPSR Price History

BPSR Stock News Headlines

July 28, 2023 | finanznachrichten.de
Organicell Regenerative Medicine, Inc.: Organicell Reports Interim Results of Phase 1/2A Research Program
July 26, 2023 | finance.yahoo.com
Organicell Reports Interim Results of Phase 1/2A Research Program
September 22, 2023 | Behind the Markets (Ad)
BREAKING: The truth about war with China
Foreign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.
June 29, 2023 | finanznachrichten.de
Organicell Regenerative Medicine, Inc.: Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSO
June 29, 2023 | finance.yahoo.com
Organicell Welcomes Howard Golub, MD, PhD As Its New EVP/CSO
June 23, 2023 | finanznachrichten.de
Organicell Regenerative Medicine, Inc.: Organicell Welcomes Harry Leider, MD, MBA as its New CEO
June 22, 2023 | marketwatch.com
8-K: Organicell Regenerative Medicine, Inc.
June 21, 2023 | finance.yahoo.com
Organicell Welcomes Harry Leider, MD, MBA as its New CEO
September 22, 2023 | Behind the Markets (Ad)
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
May 5, 2023 | marketwatch.com
Global Regenerative Medicine Market [2023-2030] | Latest Trends and Insights | Market to Reach Worth USD 116410 Million
May 4, 2023 | bbc.com
Can regenerative wool make fashion more sustainable?
April 6, 2023 | investing.com
Organicell Regenerative Medicine Inc (OCEL)
April 5, 2023 | seekingalpha.com
OCEL Organicell Regenerative Medicine, Inc.
March 29, 2023 | marketwatch.com
Regenerative Medicine Market Trends for Future Success 2023-2028
March 29, 2023 | marketwatch.com
Regenerative Medicine Market 2023: Growing Opportunities by 2028
March 18, 2023 | finance.yahoo.com
Regenerative Medicine Market Report 2023-2033
February 22, 2023 | finance.yahoo.com
Mount Vernon, IN Regenerative Medicine Procedures Launched By NuYou Therapies
January 17, 2023 | marketwatch.com
Regenerative Medicine Market Regional Outlook & Size Projections with SWOT Analysis to Witness Rapid Growth 2026
January 14, 2023 | finance.yahoo.com
Regenerative Medicine Market to Touch USD 41.4 Billion by 2028 owing to Rising Chronic Medical Ailments
January 14, 2023 | marketwatch.com
Regenerative Medicine for Cartilage Market Industry Expansion Strategies till 2028 with SWOT & RISK Analysis
January 14, 2023 | wsj.com
Organicell Regenerative Medicine Inc.
January 11, 2023 | finance.yahoo.com
The Center for Regenerative Medicine Offers State-of-the-Art Non Surgical Solutions for Arthritic Conditions
January 7, 2023 | finance.yahoo.com
Regenerative Medicine Market worth $40.6 billion by 2027 - Exclusive Report by MarketsandMarkets™
November 22, 2022 | finance.yahoo.com
OTCMKTS : OCEL 📋 Organicell Starts Enrolling Long COVID Trial 😷
November 17, 2022 | ca.finance.yahoo.com
Organicell Starts Enrolling Long COVID Trial
November 17, 2022 | yahoo.com
Can This Company’s Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
November 14, 2022 | markets.businessinsider.com
EQS-News: Can This Companys Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
See More Headlines
Receive BPSR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Organicell Regenerative Medicine and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Biotechnology
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:BPSR
CUSIP
N/A
CIK
1557376
Web
www.bespoketricycles.com
Phone
(888) 963-7881
Fax
N/A
Employees
18
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover
Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Albert MitraniAlbert Mitrani
    President, CEO, COO, Secretary & Treasurer
  • Ian T. BothwellIan T. Bothwell
    Chief Financial Officer & Director
  • Maria Ines MitraniMaria Ines Mitrani
    Director, Chief Science Officer & Vice President
  • George Craig Shapiro
    Director & Chief Medical Officer

Key Competitors

View All Competitors













BPSR Stock - Frequently Asked Questions

How have BPSR shares performed in 2023?

Organicell Regenerative Medicine's stock was trading at $0.0199 at the beginning of the year. Since then, BPSR shares have decreased by 39.7% and is now trading at $0.0120.
View the best growth stocks for 2023 here.

What other stocks do shareholders of Organicell Regenerative Medicine own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Organicell Regenerative Medicine investors own include Ciena (CIEN), Orbit Garant Drilling (OGD), Royal Caribbean Cruises (RCL), Synergy Pharmaceuticals (SGYP), Achillion Pharmaceuticals (ACHN), Aurora Cannabis (ACB), ACADIA Pharmaceuticals (ACAD), Arbutus Biopharma (ABUS) and Abacus Property Group (ABP).

What is Organicell Regenerative Medicine's stock symbol?

Organicell Regenerative Medicine trades on the OTCMKTS under the ticker symbol "BPSR."

How do I buy shares of Organicell Regenerative Medicine?

Shares of BPSR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Organicell Regenerative Medicine's stock price today?

One share of BPSR stock can currently be purchased for approximately $0.01.

How can I contact Organicell Regenerative Medicine?

Organicell Regenerative Medicine's mailing address is 4045 Sheridan Avenue,Suite 239, MIAMI, FL 33140, United States. The official website for the company is www.bespoketricycles.com. The company can be reached via phone at (888) 963-7881.

This page (OTCMKTS:BPSR) was last updated on 9/22/2023 by MarketBeat.com Staff

My Account -